AiNaNo.ru
Заметки о нанотехнологиях и не только
-
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and Jonathan Schneck, MD, PhD as Chairman of Clinical and Scientific Advisory Board: Licenses Technology From The Johns Hopkins University
Я буду первым!NexImmune, an early stage biopharmaceutical company, announced today the appointment of Kenneth Carter, PhD, as the company’s President and Chief Executive Officer, and Professor Jonathan Schneck, MD,…
Published on Январь 5, 2012 · Категории: Nanotech, Нанотехнологии;
